These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9627165)

  • 41. Adrenocortical scavenger receptor class B type I deficiency exacerbates endotoxic shock and precipitates sepsis-induced mortality in mice.
    Gilibert S; Galle-Treger L; Moreau M; Saint-Charles F; Costa S; Ballaire R; Couvert P; Carrié A; Lesnik P; Huby T
    J Immunol; 2014 Jul; 193(2):817-26. PubMed ID: 24935924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cellular basis of septic shock.
    Sommers MS
    Crit Care Nurs Clin North Am; 2003 Mar; 15(1):13-25. PubMed ID: 12597036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endotoxin tolerance: new mechanisms, molecules and clinical significance.
    Biswas SK; Lopez-Collazo E
    Trends Immunol; 2009 Oct; 30(10):475-87. PubMed ID: 19781994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular mechanisms involved in the pathogenesis of septic shock.
    López-Bojórquez LN; Dehesa AZ; Reyes-Terán G
    Arch Med Res; 2004; 35(6):465-79. PubMed ID: 15631870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Bacterial endotoxins and their effects].
    Bertók L
    Orv Hetil; 1998 Aug; 139(33):1947-53. PubMed ID: 9734211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endotoxin, septic shock and acute lung injury: neutrophils, macrophages and inflammatory mediators.
    Welbourn CR; Young Y
    Br J Surg; 1992 Oct; 79(10):998-1003. PubMed ID: 1422741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Innate immune system recognition of microbial pathogens.
    Tobias PS; Lee H; Orr S; Soldau K; Tapping R
    Immunol Res; 2000; 21(2-3):341-3. PubMed ID: 10852135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malaria, piroplasmosis and endotoxin.
    Cox FE
    Nature; 1978 Jul; 274(5669):312. PubMed ID: 672953
    [No Abstract]   [Full Text] [Related]  

  • 49. Therapeutic immunomodulatory approaches for the control of systemic inflammatory response syndrome and the prevention of sepsis.
    Faist E; Kim C
    New Horiz; 1998 May; 6(2 Suppl):S97-102. PubMed ID: 9654318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenic effects of endotoxin.
    Zivot JB; Hoffman WD
    New Horiz; 1995 May; 3(2):267-75. PubMed ID: 7583168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Endogenous intoxication in surgery: current aspects of biology and medicine. I. Genesis].
    Kharkov AL
    Klin Khir; 1997; (9-10):84-8. PubMed ID: 9511349
    [No Abstract]   [Full Text] [Related]  

  • 52. Outcome of patients with sepsis and septic shock after ICU treatment.
    Schoenberg MH; Weiss M; Radermacher P
    Langenbecks Arch Surg; 1998 Mar; 383(1):44-8. PubMed ID: 9627170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia.
    Grobmyer SR; Barie PS; Nathan CF; Fuortes M; Lin E; Lowry SF; Wright CD; Weyant MJ; Hydo L; Reeves F; Shiloh MU; Ding A
    Crit Care Med; 2000 May; 28(5):1276-82. PubMed ID: 10834665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Is there a reliable immunotherapy in infection?].
    Grimminger F; Mayer K; Seeger W
    Internist (Berl); 1997 Jun; 38(6):541-52. PubMed ID: 9264999
    [No Abstract]   [Full Text] [Related]  

  • 55. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipopolysaccharide (LPS) from the cellular wall of Gram-negative bacteria, also known as endotoxin, is a key molecule in the pathogenesis of sepsis and septic shock. Preface.
    Ronco C
    Blood Purif; 2014; 37 Suppl 1():1. PubMed ID: 24457486
    [No Abstract]   [Full Text] [Related]  

  • 57. [Postoperative sepsis: diagnosis, special features, management].
    Utzolino S; Hopt UT; Kaffarnik M
    Zentralbl Chir; 2010 Jun; 135(3):240-8. PubMed ID: 20549587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thirty years of anti-mediator treatment in sepsis and septic shock--what have we learned?
    Neugebauer E; Rixen D; Raum M; Schäfer U
    Langenbecks Arch Surg; 1998 Mar; 383(1):26-34. PubMed ID: 9627168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The systemic inflammatory response syndrome (SIRS): immunology and potential immunotherapy.
    Darville T; Giroir B; Jacobs R
    Infection; 1993; 21(5):279-90. PubMed ID: 8300243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New strategies in nonantibiotic treatment of gram-negative sepsis.
    Cohn J; Bone RC
    Cleve Clin J Med; 1992; 59(6):608-15. PubMed ID: 1424072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.